KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Gross Margin: 2020-2025

Historic Gross Margin for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to 78.95%.

  • Ginkgo Bioworks Holdings' Gross Margin fell 984.00% to 78.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 81.66%, marking a year-over-year decrease of 452.00%. This contributed to the annual value of 83.02% for FY2024, which is 152.00% up from last year.
  • As of Q3 2025, Ginkgo Bioworks Holdings' Gross Margin stood at 78.95%, which was down 2.49% from 80.97% recorded in Q2 2025.
  • In the past 5 years, Ginkgo Bioworks Holdings' Gross Margin ranged from a high of 102.50% in Q4 2023 and a low of -156.28% during Q1 2023.
  • For the 3-year period, Ginkgo Bioworks Holdings' Gross Margin averaged around 44.51%, with its median value being 80.97% (2025).
  • In the last 5 years, Ginkgo Bioworks Holdings' Gross Margin tumbled by 12,444bps in 2023 and then spiked by 23,202bps in 2024.
  • Ginkgo Bioworks Holdings' Gross Margin (Quarterly) stood at -9.15% in 2021, then crashed by 10,313bps to -112.28% in 2022, then spiked by 21,478bps to 102.50% in 2023, then tumbled by 1,973bps to 82.77% in 2024, then plummeted by 984bps to 78.95% in 2025.
  • Its last three reported values are 78.95% in Q3 2025, 80.97% for Q2 2025, and 83.53% during Q1 2025.